HIGHLIGHTS
- who: Zehua Wang and collaborators from the Xi`an University, China have published the paper: Chimeric antigen receptor T-cell therapy for multiple myeloma, in the Journal: (JOURNAL)
- future: Future studies might discover other approaches to upregulate BCMA expression. But this trial continues to enroll more patients and follow-up data will be updated in the future .
SUMMARY
A conceivable side effect is the depletion of SLAMF7+ lymphocytes, including a substantial proportion of T_cells, B cells, and NK cells. It would be reasonable to engineer SLAMF7CAR T_cells with a safety switch . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.